BEKANNTGABEN DER HERAUSGEBER: Bundesärztekammer
Aus der UAW-Datenbank: Isotretinoin und chronisch-entzündliche Darmerkrankung
Dtsch Arztebl 2012; 109(20): A-1044 / B-900 / C-892
| 1. | Schwabe U, Paffrath D (Hrsg.): Arzneiverordnungs-Report 2011. Berlin, Heidelberg: Springer Medizin Verlag, 2011. |
| 2. | Reddy D, Siegel CA, Sands BE, Kane S: Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006; 101: 1569–73. CrossRef MEDLINE |
| 3. | Bernstein CN, Nugent Z, Longobardi T, Blanchard JF: Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am J Gastroenterol 2009; 104: 2774–8. CrossRef MEDLINE |
| 4. | Crockett SD, Porter CQ, Martin CF, et al.: Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol 2010; 105: 1986–93. CrossRef MEDLINE PubMed Central |
| 5. | Popescu CM, Popescu R: Isotretinoin therapy and inflammatory bowel disease. Arch Dermatol 2011; 147: 724–9. CrossRef MEDLINE |
| 6. | Shaw SY, Blanchard JF, Bernstein CN: Association between the use of antibiotics and new diagnoses of Crohn’s disease and ulcerative colitis. Am J Gastroenterol 2011; 106: 2133–42. CrossRef MEDLINE |
